Sign Up
OverviewAPI
US publicly traded health insurers saw revenue growth in 2023 but face margin pressure in 2024 due to declining reimbursement rates. Eli Lilly anticipates a significant rise in sales driven by Mounjaro and Zepbound. The global mutual insurance sector's market share reached an eight-year high, emphasizing its financial strength and resilience.

Ask a question